Physician profile
Aimee P Mitchell
NPI 1366882219
$2,250.24
in general payments reported to CMS, 2019-2025
22 companies · $245 in 2025
The $245 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $89.20 · 2022: $405 · 2023: $1,249 · 2024: $262 · 2025: $245.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,656 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,656.30 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Women'S Health, INC. | $593.30 | 2023 | Myrisk |
| Astellas Pharma US INC | $327.02 | 2023-2025 | Veozah |
| Abbvie INC. | $304.43 | 2021-2023 | |
| Mayne Pharma Commercial LLC | $143.60 | 2021-2023 | |
| Sumitomo Pharma America, INC. | $131.95 | 2023 | Myfembree |
| Amgen INC. | $106.28 | 2021-2025 | Evenity, Prolia |
| Sanofi-Aventis U.S. LLC | $96.50 | 2024 | |
| Pfizer INC. | $81.07 | 2022-2023 | |
| Medtronic, INC. | $68.70 | 2022-2025 | Endurant Iis |
| Bayer Healthcare Pharmaceuticals INC. | $63.27 | 2022-2023 | |
| Corcept Therapeutics | $52.41 | 2025 | Korlym |
| Myovant Sciences INC. | $51.35 | 2022 | |
| Daiichi Sankyo INC. | $50.13 | 2021-2022 | |
| Exeltis, USA INC. | $45.51 | 2023 | Slynd |
| Abbott Laboratories | $20.43 | 2024 | Freestyle Libre 3 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $18.34 | 2022 | |
| Shield Therapeutics INC | $18.21 | 2025 | |
| Heron Therapeutics, INC. | $16.90 | 2022 | |
| Evofem Biosciences, INC. | $16.63 | 2021 | |
| Lilly USA, LLC | $16.05 | 2025 | Zepbound |
| Optumhealth Care Solutions, LLC | $14.16 | 2023 | Vivify Health Care Team Portal |
| Novartis Pharmaceuticals Corporation | $14.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aimee Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.